The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Macrovascular Complications in Patients with Diabetes and Prediabetes
Open accessAbstract
Diabetes is a significant health problem worldwide, and its association with cardiovascular disease (CVD) was reported in several studies. Hyperglycemia and insulin resistance seen in diabetes and prediabetes lead to an increase in reactive oxygen species, which triggers intracellular molecular signaling. The resulting prothrombotic state and increase in inflammatory mediators expedite atherosclerotic changes and the development of macrovascular complications. Individuals with diabetes or prediabetes have a higher risk of developing myocardial infarction, stroke, and peripheral artery disease. However, no significant difference in cardiovascular morbidity has been observed with tight glycemic control despite a reduction in some CVD outcomes, and the risk of adverse outcomes such as hypoglycemia was increased. Recently, some GLP-1 receptor agonists and SGLT-2 inhibitors have been shown to reduce cardiovascular events and mortality. In this review we give an overview of the risk and pathogenesis of cardiovascular disease among diabetic and prediabetic patients, as well as the implication of recent changes in diabetes management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629 · cited 1×
“In the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) trial, liraglutide was superior to placebo in reducing major cardiovascular events when added to the conventional treatment of individuals with T2DM at high cardiovascular risk [71].”
BackgroundIntensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
O'Donnell, M. J., Xavier, D., Liu, L., Zhang, H., Chin, S. L., Rao-Melacini, P., Rangarajan, S., Islam, S., Pais, P., McQueen, M. J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60834-3 · Cited by 3,448 · cited 1×
“The INTERSTROKE study, which is a case-control study that recruited patients who developed acute stroke and those without a stroke history in 22 countries, demonstrated a 35% increase in stroke risk in patients with self-reported history of diabetes [30].”
BackgroundPeripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care
Hirsch, A. T. (2001) · JAMA · doi:10.1001/jama.286.11.1317 · Cited by 2,835
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
Pfeffer, M. A., Claggett, B., Diaz, R., Dickstein, K., Gerstein, H. C., Køber, L. V., Lawson, F. C., Ping, L., Wei, X., Lewis, E. F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509225 · Cited by 2,409
Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes
Holman, R. R., Bethel, M. A., Mentz, R. J., Thompson, V. P., Lokhnygina, Y., Buse, J. B., Chan, J. C., Choi, J., Gustavson, S. M., Iqbal, N., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612917 · Cited by 2,162
Kim, J.-A., Montagnani, M., Koh, K. K., & Quon, M. J. (2006) · Circulation · doi:10.1161/circulationaha.105.563213 · Cited by 1,652
Inoguchi, T., Li, P., Umeda, F., Yu, H. Y., Kakimoto, M., Imamura, M., Aoki, T., Etoh, T., Hashimoto, T., Naruse, M., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1939 · Cited by 1,577
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
Paneni, F., Beckman, J. A., Creager, M. A., & Cosentino, F. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht149 · Cited by 1,401
Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes
and the WHO Multinational Study Group, Morrish, N. J., Wang, S.-L., Stevens, L. K., Fuller, J. H., & Keen, H. (2001) · Diabetologia · doi:10.1007/pl00002934 · Cited by 1,288
Intensive glucose control and macrovascular outcomes in type 2 diabetes
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1470-0 · Cited by 1,189
Tominaga, M., Eguchi, H., Manaka, H., Igarashi, K., Kato, T., & Sekikawa, A. (1999) · Diabetes Care · doi:10.2337/diacare.22.6.920 · Cited by 1,165
Norhammar, A., Tenerz, Å., Nilsson, G., Hamsten, A., Efendíc, S., Rydén, L., & Malmberg, K. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09089-x · Cited by 1,112
Writing committee, Unwin, N., Shaw, J., Zimmet, P., & Alberti, K. G. M. M. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00835.x · Cited by 1,108
Huang, Y., Cai, X., Mai, W., Li, M., & Hu, Y. (2016) · BMJ · doi:10.1136/bmj.i5953 · Cited by 1,012
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
Geraldes, P., & King, G. L. (2010) · Circulation Research · doi:10.1161/circresaha.110.217117 · Cited by 985
Du, X. L., Edelstein, D., Dimmeler, S., Ju, Q., Sui, C., & Brownlee, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11235 · Cited by 907
Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971–1993
Gu, K., Cowie, C. C., & Harris, M. I. (1998) · Diabetes Care · doi:10.2337/diacare.21.7.1138 · Cited by 881
Wiviott, S. D., Braunwald, E., Angiolillo, D. J., Meisel, S., Dalby, A. J., Verheugt, F. W. A., Goodman, S. G., Corbalan, R., Purdy, D. A., Murphy, S. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.791061 · Cited by 754
Platelet Dysfunction in Type 2 Diabetes
Vinik, A. I., Erbas, T., Park, T. S., Nolan, R., & Pittenger, G. L. (2001) · Diabetes Care · doi:10.2337/diacare.24.8.1476 · Cited by 671
Kuchulakanti, P. K., Chu, W. W., Torguson, R., Ohlmann, P., Rha, S.-W., Clavijo, L. C., Kim, S.-W., Bui, A., Gevorkian, N., Xue, Z., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.600155 · Cited by 639
BARTNIK, M. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.07.027 · Cited by 617
de Vegt, F., Dekker, J. M., Ruhé, H. G., Stehouwer, C. D. A., Nijpels, G., Bouter, L. M., & Heine, R. J. (1999) · Diabetologia · doi:10.1007/s001250051249 · Cited by 613
Schramm, T. K., Gislason, G. H., Køber, L., Rasmussen, S., Rasmussen, J. N., Abildstrøm, S. Z., Hansen, M. L., Folke, F., Buch, P., Madsen, M., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.720847 · Cited by 538
The DECODE Study Group, & on behalf of the European Diabetes Epidemiology Group (2003) · Diabetes Care · doi:10.2337/diacare.26.3.688 · Cited by 516
Fasting and Postchallenge Glycemia and Cardiovascular Disease Risk
Meigs, J. B., Nathan, D. M., D’Agostino, R. B., & Wilson, P. W. F. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1845 · Cited by 509
Wei, M., Gaskill, S. P., Haffner, S. M., & Stern, M. P. (1998) · Diabetes Care · doi:10.2337/diacare.21.7.1167 · Cited by 473
Standards of Medical Care in Diabetes—2017: Summary of Revisions
(2017) · Diabetes Care · doi:10.2337/dc17-s003 · Cited by 425
Is diabetes a coronary risk equivalent? Systematic review and meta‐analysis
Bulugahapitiya, U., Siyambalapitiya, S., Sithole, J., & Idris, I. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02640.x · Cited by 377
Roussel, R. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.409 · Cited by 361
Systematic review: glucose control and cardiovascular disease in type 2 diabetes
Kelly, T. N., Bazzano, L. A., Fonseca, V. A., Thethi, T. K., Reynolds, K., & He, J. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-6-200909150-00137 · Cited by 358 · cited 1×
“The CVD-associated mortality and overall mortality, however, were not significantly different, and the risk of hypoglycemia is higher in the intensive therapy group than the standard treatment group [65, 66].”
BackgroundDu, X., Edelstein, D., Obici, S., Higham, N., Zou, & Brownlee, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci23354 · Cited by 347
Peripheral arterial disease in diabetes—a review
Jude, E. B., Eleftheriadou, I., & Tentolouris, N. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02866.x · Cited by 320
Trends in Death Rates Among U.S. Adults With and Without Diabetes Between 1997 and 2006
Gregg, E. W., Cheng, Y. J., Saydah, S., Cowie, C., Garfield, S., Geiss, L., & Barker, L. (2012) · Diabetes Care · doi:10.2337/dc11-1162 · Cited by 303
van Wijk, I., Kappelle, L., van Gijn, J., Koudstaal, P., Franke, C., Vermeulen, M., Gorter, J., & Algra, A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66734-7 · Cited by 295
Chaudhuri, A., Janicke, D., Wilson, M. F., Tripathy, D., Garg, R., Bandyopadhyay, A., Calieri, J., Hoffmeyer, D., Syed, T., Ghanim, H., et al. (2004) · Circulation · doi:10.1161/01.cir.0000116762.77804.fc · Cited by 277
Gerstein, H. C., Pogue, J., Mann, J. F. E., Lonn, E., Dagenais, G. R., McQueen, M., Yusuf, S., & HOPE investigators (2005) · Diabetologia · doi:10.1007/s00125-005-1858-4 · Cited by 262
Lowe, L. P., Liu, K., Greenland, P., Metzger, B. E., Dyer, A. R., & Stamler, J. (1997) · Diabetes Care · doi:10.2337/diacare.20.2.163 · Cited by 235
Knoflach, M., Matosevic, B., Rücker, M., Furtner, M., Mair, A., Wille, G., Zangerle, A., Werner, P., Ferrari, J., Schmidauer, C., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31824367ab · Cited by 226
Machecourt, J., Danchin, N., Lablanche, J. M., Fauvel, J. M., Bonnet, J. L., Marliere, S., Foote, A., Quesada, J. L., Eltchaninoff, H., & Vanzetto, G. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.051 · Cited by 207
Relationship between diabetes and mortality: a population study using record linkage.
Morgan, C. L., Currie, C. J., & Peters, J. R. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1103 · Cited by 182
Hasegawa, Y., Saito, T., Ogihara, T., Ishigaki, Y., Yamada, T., Imai, J., Uno, K., Gao, J., Kaneko, K., Shimosawa, T., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.054346 · Cited by 169
Natural history of claudication: Long-term serial follow-up study of 1244 claudicants
Aquino, R., Johnnides, C., Makaroun, M., Whittle, J. C., Muluk, V. S., Kelley, M. E., & Muluk, S. C. (2001) · Journal of Vascular Surgery · doi:10.1067/mva.2001.119749 · Cited by 163
Diabetes and Poor Outcomes Within 6 Months After Acute Ischemic Stroke
Jia, Q., Zhao, X., Wang, C., Wang, Y., Yan, Y., Li, H., Zhong, L., Liu, L., Zheng, H., Zhou, Y., et al. (2011) · Stroke · doi:10.1161/strokeaha.111.621649 · Cited by 150
Reaven, P. D., Sacks, J. M., & Investigators for the VADT (2005) · Diabetologia · doi:10.1007/s00125-004-1640-z · Cited by 144
Charles, M., Ejskjær, N., Witte, D. R., Borch‐Johnsen, K., Lauritzen, T., & Sandbæk, A. (2011) · Diabetes Care · doi:10.2337/dc11-0903 · Cited by 123
Clairotte, C., Retout, S., Potier, L., Roussel, R., & Escoubet, B. (2009) · Diabetes Care · doi:10.2337/dc08-2230 · Cited by 119
Trends in the Risk for Coronary Heart Disease Among Adults With Diagnosed Diabetes in the U.S.
Ford, E. S. (2011) · Diabetes Care · doi:10.2337/dc10-2251 · Cited by 114
Lange, S., Diehm, C., Darius, H., Haberl, R., Allenberg, J., Pittrow, D., Schuster, A., von Stritzky, B., Tepohl, G., & Trampisch, H. (2004) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2004-830408 · Cited by 101
Trends in Lower-Extremity Amputations in People With and Without Diabetes in Spain, 2001–2008
López‐de‐Andrés, A., Martinez-Huedo, M. A., Carrasco‐Garrido, P., et al. (2011) · Diabetes Care · doi:10.2337/dc11-0077 · Cited by 99
Lazzarini, P. A., O'Rourke, S. R., Russell, A. W., Derhy, P. H., & Kamp, M. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130609 · Cited by 95
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Marso, S. P., Holst, A. G., & Vilsbøll, T. (2017) · PubMed · doi:10.1056/nejmc1615712 · Cited by 77
Jensen, L. O., Mæng, M., Thayssen, P., Tilsted, H. H., Terkelsen, C. J., Kaltoft, A., Lassen, J. F., Hansen, K. N., Ravkilde, J., Christiansen, E. H., et al. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.10.018 · Cited by 65
Wu, C., Yang, C., Tsai, C., Chiu, F., Huang, Y.-T., Lee, J., Cheng, C.-L., Lin, L., Lin, J., Hwang, J., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.08.038 · Cited by 62
Woods, S. E., Smith, J. M., Sohail, S., et al. (2004) · CHEST Journal · doi:10.1378/chest.126.6.1789 · Cited by 52
Glucose in prediabetic and diabetic range and outcome after stroke
Osei, E., Fonville, S., Zandbergen, A. A. M., Koudstaal, P. J., Dippel, D. W. J., & den Hertog, H. M. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12577 · Cited by 37
Winell, K., Pääkkönen, R., Pietilä, A., Reunanen, A., Niemi, M., & Salomaa, V. V. (2011) · International Journal of Stroke · doi:10.1111/j.1747-4949.2010.00567.x · Cited by 21
Fhärm, E., Cederholm, J., Eliasson, B., Guðbjörnsdóttir, S., & Rolandsson, O. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03425.x · Cited by 17
Yokoyama, H., Sone, H., Honjo, J., Okizaki, S.-I., Yamada, D., Shudo, R., Shimizu, H., Moriya, T., & Haneda, A. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.22491 · Cited by 16
Winell, K., Pietilä, A., Niemi, M., Reunanen, A., & Salomaa, V. V. (2011) · Diabetologia · doi:10.1007/s00125-011-2262-x · Cited by 8
Variation and Trends in Lower Extremity Amputation Rates in Los Angeles County Hospitals 2000-2010
Jindeel, A., Gessert, C. E., & Johnson, B. P. (2016) · The International Journal of Lower Extremity Wounds · doi:10.1177/1534734616653843 · Cited by 7
Chang, L.-H., Hwu, C., Chu, C., Won, J. G. S., Kwok, C., Lin, H.-D., Chen, H.-S., Lin, Y., & Lin, L. (2016) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2016.02.035 · Cited by 6
Cited by
Glycemic variability and cardiovascular disease in patients with type 2 diabetes
Martinez, M., Santamarina, J., Pavesi, A., Musso, C., & Umpierrez, G. E. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-002032 · Cited by 155
Peña-Jorquera, H., Cid-Jofré, V., Landaeta-Díaz, L., Petermann-Rocha, F., Martorell, M., Zbinden-Foncea, H., Ferrari, G., Jorquera-Aguilera, C., & Cristi-Montero, C. (2023) · Nutrients · doi:10.3390/nu15143244 · Cited by 103
Hashemi Madani, N., Ismail-Beigi, F., Poustchi, H., Nalini, M., Sepanlou, S. G., Malek, M., Abbasi, M. A., Khajavi, A., Khamseh, M. E., & Malekzadeh, R. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01390-8 · Cited by 22
Ansari, P., Khan, J. T., Choudhary, S., Reberio, A. D., Kumar, S., Seidel, V., Abdel-Wahab, Y. H. A., & Flatt, P. R. (2024) · doi:10.20944/preprints202408.1739.v1 · Cited by 89
Metadata
- Authors
- Huang, D., Refaat, M., Mohammedi, K., Jayyousi, A., Al Suwaidi, J., & Abi Khalil, C.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2017
- Volume
- 2017
- Pages
- 1-9
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W2767450049
- Cited by
- 278
- References
- 74
- FWCI
- 13.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.